位置:首页 > 蛋白库 > DAXX_CANLF
DAXX_CANLF
ID   DAXX_CANLF              Reviewed;         737 AA.
AC   Q5TJE1;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   03-AUG-2022, entry version 101.
DE   RecName: Full=Death domain-associated protein 6;
DE   AltName: Full=Daxx;
GN   Name=DAXX;
OS   Canis lupus familiaris (Dog) (Canis familiaris).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis.
OX   NCBI_TaxID=9615;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Doberman pinscher;
RX   PubMed=15607421; DOI=10.1016/j.ygeno.2004.09.009;
RA   Debenham S.L., Hart E.A., Ashurst J.L., Howe K.L., Quail M.A.,
RA   Ollier W.E.R., Binns M.M.;
RT   "Genomic sequence of the class II region of the canine MHC: comparison with
RT   the MHC of other mammalian species.";
RL   Genomics 85:48-59(2005).
CC   -!- FUNCTION: Transcription corepressor known to repress transcriptional
CC       potential of several sumoylated transcription factors. Down-regulates
CC       basal and activated transcription. Its transcription repressor activity
CC       is modulated by recruiting it to subnuclear compartments like the
CC       nucleolus or PML/POD/ND10 nuclear bodies through interactions with
CC       MCSR1 and PML, respectively. Seems to regulate transcription in
CC       PML/POD/ND10 nuclear bodies together with PML and may influence
CC       TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional
CC       activation of PAX3 and ETS1 through direct protein-protein
CC       interactions. Modulates PAX5 activity; the function seems to involve
CC       CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by
CC       regulating the RING-finger E3 ligase MDM2 ubiquitination activity.
CC       Under non-stress condition, in association with the deubiquitinating
CC       USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3
CC       ligase activity of MDM2 towards TP53, thereby promoting TP53
CC       ubiquitination and subsequent proteasomal degradation. Upon DNA damage,
CC       its association with MDM2 and USP7 is disrupted, resulting in increased
CC       MDM2 autoubiquitination and consequently, MDM2 degradation, which leads
CC       to TP53 stabilization. Acts as histone chaperone that facilitates
CC       deposition of histone H3.3. Acts as targeting component of the
CC       chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA
CC       translocase activity and catalyzes the replication-independent
CC       deposition of histone H3.3 in pericentric DNA repeats outside S-phase
CC       and telomeres, and the in vitro remodeling of H3.3-containing
CC       nucleosomes. Does not affect the ATPase activity of ATRX but alleviates
CC       its transcription repression activity. Upon neuronal activation
CC       associates with regulatory elements of selected immediate early genes
CC       where it promotes deposition of histone H3.3 which may be linked to
CC       transcriptional induction of these genes. Required for the recruitment
CC       of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process
CC       is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested
CC       to function as regulatory sites for the incorporation of newly
CC       synthesized histone H3.3 into chromatin. Proposed to mediate activation
CC       of the JNK pathway and apoptosis via MAP3K5 in response to signaling
CC       from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent
CC       interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis.
CC       In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated
CC       apoptosis may not involve DAXX (By similarity). Plays a role as a
CC       positive regulator of the heat shock transcription factor HSF1 activity
CC       during the stress protein response (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q9UER7}.
CC   -!- SUBUNIT: Homomultimer. Interacts (via C-terminus) with TNFRSF6 (via
CC       death domain). Interacts with PAX5, SLC2A4/GLUT4, MAP3K5, TGFBR2,
CC       phosphorylated dimeric HSPB1/HSP27, CENPC, ETS1, sumoylated PML, UBE2I,
CC       MCRS1 and TP53. Interacts (via N-terminus) with HIPK2 and HIPK3.
CC       Interacts with HIPK1, which induces translocation from PML/POD/ND10
CC       nuclear bodies to chromatin and enhances association with HDAC1.
CC       Interacts (non-phosphorylated) with PAX3, PAX7, DEK, HDAC1, HDAC2,
CC       HDAC3, acetylated histone H4 and histones H2A, H2B, H3, H3.3 and H4.
CC       Interacts with SPOP; mediating CUL3-dependent proteosomal degradation.
CC       Interacts with CBP; the interaction is dependent the sumoylation of CBP
CC       and suppresses CBP transcriptional activity via recruitment of HDAC2
CC       directly in the complex with TP53 and HIPK2. Interacts with AXIN1; the
CC       interaction stimulates the interaction of DAXX with TP53, stimulates
CC       'Ser-46' phosphorylation of TP53 on and induces cell death on UV
CC       irradiation. Interacts with MDM2; the interaction is direct. Interacts
CC       with USP7; the interaction is direct and independent of MDM2 and TP53.
CC       Part of a complex with DAXX, MDM2 and USP7 under non-stress conditions.
CC       Interacts (via N-terminus) with RASSF1 (via C-terminus); the
CC       interaction is independent of MDM2 and TP53; RASSF1 isoform A disrupts
CC       interactions among MDM2, DAXX and USP7, thus contributing to the
CC       efficient activation of TP53 by promoting MDM2 self-ubiquitination in
CC       cell-cycle checkpoint control in response to DNA damage. Interacts with
CC       ATRX to form the chromatin remodeling complex ATRX:DAXX (By
CC       similarity). Interacts with HSF1 (via homotrimeric form
CC       preferentially); this interaction relieves homotrimeric HSF1 from
CC       repression of its transcriptional activity by HSP90-dependent
CC       multichaperone complex upon heat shock (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q9UER7}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9UER7}.
CC       Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9UER7}. Nucleus, PML body
CC       {ECO:0000250|UniProtKB:Q9UER7}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q9UER7}. Chromosome, centromere
CC       {ECO:0000250|UniProtKB:Q9UER7}. Note=Dispersed throughout the
CC       nucleoplasm, in PML/POD/ND10 nuclear bodies, and in nucleoli.
CC       Colocalizes with histone H3.3, ATRX, HIRA and ASF1A at PML-nuclear
CC       bodies. Colocalizes with a subset of interphase centromeres, but is
CC       absent from mitotic centromeres. Detected in cytoplasmic punctate
CC       structures. Translocates from the nucleus to the cytoplasm upon glucose
CC       deprivation or oxidative stress. Colocalizes with RASSF1 in the
CC       nucleus. Colocalizes with USP7 in nucleoplasma with accumulation in
CC       speckled structures. {ECO:0000250|UniProtKB:Q9UER7}.
CC   -!- DOMAIN: The Sumo interaction motif mediates Sumo binding, and is
CC       required both for sumoylation and binding to sumoylated targets.
CC       {ECO:0000250}.
CC   -!- PTM: Sumoylated with SUMO1 on multiple lysine residues. {ECO:0000250}.
CC   -!- PTM: Polyubiquitinated; which is promoted by CUL3 and SPOP and results
CC       in proteasomal degradation. Ubiquitinated by MDM2; inducing its
CC       degradation. Deubiquitinated by USP7; leading to stabilize it (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the DAXX family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ630366; CAI11447.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q5TJE1; -.
DR   SMR; Q5TJE1; -.
DR   STRING; 9612.ENSCAFP00000001395; -.
DR   PaxDb; Q5TJE1; -.
DR   Ensembl; ENSCAFT00845038086; ENSCAFP00845029838; ENSCAFG00845021574.
DR   VEuPathDB; HostDB:ENSCAFG00845021574; -.
DR   eggNOG; ENOG502QRS6; Eukaryota.
DR   GeneTree; ENSGT00390000009448; -.
DR   InParanoid; Q5TJE1; -.
DR   Proteomes; UP000002254; Chromosome 12.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0050681; F:nuclear androgen receptor binding; IEA:Ensembl.
DR   GO; GO:0002039; F:p53 binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0030295; F:protein kinase activator activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0047485; F:protein N-terminus binding; IEA:Ensembl.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0140037; F:sumo-dependent protein binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0140416; F:transcription regulator inhibitor activity; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0071276; P:cellular response to cadmium ion; ISS:UniProtKB.
DR   GO; GO:0071280; P:cellular response to copper ion; ISS:UniProtKB.
DR   GO; GO:0072738; P:cellular response to diamide; ISS:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:1903936; P:cellular response to sodium arsenite; ISS:UniProtKB.
DR   GO; GO:0034620; P:cellular response to unfolded protein; ISS:UniProtKB.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
DR   GO; GO:0007254; P:JNK cascade; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:1901216; P:positive regulation of neuron death; IEA:Ensembl.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; ISS:UniProtKB.
DR   CDD; cd13151; DAXX_helical_bundle; 1.
DR   CDD; cd13150; DAXX_histone_binding; 1.
DR   Gene3D; 1.10.8.810; -; 1.
DR   Gene3D; 1.20.58.2170; -; 1.
DR   InterPro; IPR005012; Daxx.
DR   InterPro; IPR046378; DAXX_histone_binding.
DR   InterPro; IPR046426; DAXX_histone_binding_sf.
DR   InterPro; IPR031333; Daxx_N.
DR   InterPro; IPR038298; Daxx_N_sf.
DR   PANTHER; PTHR12766:SF7; PTHR12766:SF7; 1.
DR   Pfam; PF03344; Daxx; 1.
PE   3: Inferred from homology;
KW   Acetylation; Apoptosis; Centromere; Chaperone; Chromatin regulator;
KW   Chromosome; Coiled coil; Cytoplasm; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..737
FT                   /note="Death domain-associated protein 6"
FT                   /id="PRO_0000151256"
FT   REGION          1..159
FT                   /note="Necessary for interaction with USP7 and ATRX"
FT                   /evidence="ECO:0000250"
FT   REGION          1..55
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          145..184
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          182..417
FT                   /note="Interaction with histone H3.3"
FT                   /evidence="ECO:0000250"
FT   REGION          346..567
FT                   /note="Necessary for interaction with USP7"
FT                   /evidence="ECO:0000250"
FT   REGION          382..556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          569..719
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          624..737
FT                   /note="Interaction with SPOP"
FT                   /evidence="ECO:0000250"
FT   REGION          730..737
FT                   /note="Sumo interaction motif (SIM)"
FT                   /evidence="ECO:0000250"
FT   COILED          179..216
FT                   /evidence="ECO:0000255"
FT   COILED          432..474
FT                   /evidence="ECO:0000255"
FT   MOTIF           390..394
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           626..632
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        36..50
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        148..181
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        382..396
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        433..489
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        499..545
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        590..617
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        672..719
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         412
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         459
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O35613"
FT   MOD_RES         494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         497
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIB2"
FT   MOD_RES         511
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         558
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIB2"
FT   MOD_RES         578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIB2"
FT   MOD_RES         665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         668
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         685
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         699
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         734
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         736
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   CROSSLNK        142
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   CROSSLNK        628
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   CROSSLNK        629
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
SQ   SEQUENCE   737 AA;  81479 MW;  E321EB2C160C3946 CRC64;
     MATANSIIVL DDDDEDEAAA QPGPSHPPPN PASPQAEAPG SSQPHGAGGS SSSGGKKCYK
     LENEKLFEEF LELCKMQTAD HPEVVPFLYN RQQRAHSLFL ASAEFCNILS RVLSRAQSRP
     AKLYVYINEL CTVLKAHSAK KKLNLAPAAT SSEPSGNNPP TDPSSDPTNA ETTASEAPRT
     RGSRRQIQRL EQLLALYVAE IRRLQEKELD LSELDDPDST YLQEARLKRK LIRLFGRLCE
     LKDCSSLTGR VIEQRIPYRG TRYPEVNRRI ERLINKPGPD TFPDYGDVLR AVEKAAARHS
     LGLPRQQLQL MAQDAFRDVG IRLQERRHLD LIYNFGCHLT DDYRPGIDPA LSDPALARRL
     RENRSLAMSR LDEVISKYAM MQDKSEEGER QKRRARLPQA TSSHSTDPLK ASLDSGEGPS
     GMASQECPTT SKPETDDEED EESEEEEEEE EEEEEEEATD SEEEEDLEQM QEGQGDDEEE
     EEEEEEAGQD GDKSPMSPPR ISTEKNLEPS KGISRSMGEQ QNKEFTVSPS SEEPLAPSSI
     DAESNGENLE ELLLEEESPI SQLFELEIEA LPLDTTPSPE ERDISSSRKQ SEEPLTTVLE
     NGAAMVTSTS FNGGVSPHTW GDSCPPCKKS RKEKETGAEP LGNSYVERQR SVHEKNGRKI
     PTLPSPPSPL TSMAPVADSS TRVDSPSHGL VTSSLCSASQ ARLSQTPHSQ PSRPGTYKMS
     VATQCDPEEI IVLSDSD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024